Safety Study of CALAA-01 to Treat Solid Tumor Cancers

This study is ongoing, but not recruiting participants.

Sponsor:

Information provided by (Responsible Party):

Calando Pharmaceuticals

ClinicalTrials.gov Identifier:

NCT00689065

First received: May 29, 2008

Last updated: August 31, 2012

Last verified: August 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	December 2012
Estimated Primary Completion Date:	August 2012 (Final data collection date for primary outcome measure)

Publications: